The differential diagnoses for CRCC include RCC with cystic change, hereditary leiomyomatosis manifesting as a cystic renal lesion, cystic nephroma, clear cell papillary RCC, and other cystic ...

PSMA may be a noninvasive biomarker for predicting treatment response in metastatic clear cell renal cell carcinoma (RCC).

Chung et al. examine the levels of glycoprotein non-metastatic melanoma protein B (GPNMB) in the blood of patients with renal cell carcinoma who acquire resistance to immune checkpoint inhibitor ...